Li USA

Lilly USA is the United States commercial arm of Eli Lilly and Company, a global pharmaceutical leader headquartered in Indianapolis. The company specializes in the discovery, development, and commercialization of innovative medicines across several core therapeutic areas, including endocrinology, oncology, immunology, and neuroscience. Lilly is particularly recognized for its leadership in diabetes care and its recent breakthroughs in obesity treatment with incretin-based therapies like Mounjaro and Zepbound. Additionally, the company maintains a robust late-stage pipeline focused on high-unmet-need conditions such as Alzheimer's disease and various autoimmune disorders. With extensive manufacturing and R&D capabilities, Lilly USA plays a critical role in the delivery of life-changing treatments to millions of patients across the American healthcare system.